
Masoud H. Noori
Examiner (ID: 3784, Phone: (571)272-2185 , Office: P/2855 )
| Most Active Art Unit | 2855 |
| Art Unit(s) | 2855, 2214, 2856, 2616 |
| Total Applications | 3955 |
| Issued Applications | 3448 |
| Pending Applications | 170 |
| Abandoned Applications | 350 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17734640
[patent_doc_number] => 20220220099
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-14
[patent_title] => BENZAMIDE COMPOUND, AND HERBICIDE
[patent_app_type] => utility
[patent_app_number] => 17/615667
[patent_app_country] => US
[patent_app_date] => 2020-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9968
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 250
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17615667
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/615667 | BENZAMIDE COMPOUND, AND HERBICIDE | May 31, 2020 | Abandoned |
Array
(
[id] => 20343098
[patent_doc_number] => 12466820
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-11-11
[patent_title] => Amino quinazoline derivatives as P2X3 inhibitors
[patent_app_type] => utility
[patent_app_number] => 17/615017
[patent_app_country] => US
[patent_app_date] => 2020-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34636
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 286
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17615017
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/615017 | Amino quinazoline derivatives as P2X3 inhibitors | May 27, 2020 | Issued |
Array
(
[id] => 17720326
[patent_doc_number] => 20220213046
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-07
[patent_title] => 2,3-Diaryl-2,3-Dihydro-4H-1,3-Thiazin-4-One Compounds and Methods for Making
[patent_app_type] => utility
[patent_app_number] => 17/609916
[patent_app_country] => US
[patent_app_date] => 2020-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6527
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17609916
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/609916 | 2,3-diaryl-2,3-dihydro-4H-1,3-thiazin-4-one compounds and methods for making | May 20, 2020 | Issued |
Array
(
[id] => 16832070
[patent_doc_number] => 11008310
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-05-18
[patent_title] => Chromene derivatives as inhibitors of TCR-Nck interaction
[patent_app_type] => utility
[patent_app_number] => 16/878842
[patent_app_country] => US
[patent_app_date] => 2020-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 28224
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 111
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16878842
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/878842 | Chromene derivatives as inhibitors of TCR-Nck interaction | May 19, 2020 | Issued |
Array
(
[id] => 16893131
[patent_doc_number] => 11034664
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2021-06-15
[patent_title] => Synthesis of cyclic carbonate monomers
[patent_app_type] => utility
[patent_app_number] => 16/871733
[patent_app_country] => US
[patent_app_date] => 2020-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 16
[patent_no_of_words] => 8150
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16871733
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/871733 | Synthesis of cyclic carbonate monomers | May 10, 2020 | Issued |
Array
(
[id] => 16710276
[patent_doc_number] => 20210077423
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-18
[patent_title] => ANALGESIC COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 16/869797
[patent_app_country] => US
[patent_app_date] => 2020-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12513
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -35
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16869797
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/869797 | Analgesic compositions | May 7, 2020 | Issued |
Array
(
[id] => 20372384
[patent_doc_number] => 12479806
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-11-25
[patent_title] => Process for preparing XPO1 inhibitors and intermediates for use in the preparation of XPO1 inhibitors
[patent_app_type] => utility
[patent_app_number] => 17/607670
[patent_app_country] => US
[patent_app_date] => 2020-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5864
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 175
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17607670
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/607670 | Process for preparing XPO1 inhibitors and intermediates for use in the preparation of XPO1 inhibitors | Apr 30, 2020 | Issued |
Array
(
[id] => 16718517
[patent_doc_number] => 20210085664
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-25
[patent_title] => USE OF 2-SUBSTITUTED INDAZOLES FOR THE TREATMENT AND PROPHYLAXIS OF AUTOIMMUNE DISEASES
[patent_app_type] => utility
[patent_app_number] => 16/863330
[patent_app_country] => US
[patent_app_date] => 2020-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29375
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16863330
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/863330 | USE OF 2-SUBSTITUTED INDAZOLES FOR THE TREATMENT AND PROPHYLAXIS OF AUTOIMMUNE DISEASES | Apr 29, 2020 | Abandoned |
Array
(
[id] => 17749510
[patent_doc_number] => 20220227714
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-21
[patent_title] => A SCALABLE SYNTHESIS OF DUAL-TARGET INHIBITOR OF CANNABINOID-1 RECEPTOR AND INDUCIBLE NITRIC OXIDE SYNTHASE
[patent_app_type] => utility
[patent_app_number] => 17/610537
[patent_app_country] => US
[patent_app_date] => 2020-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6227
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17610537
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/610537 | Scalable synthesis of dual-target inhibitor of cannabinoid-1 receptor and inducible nitric oxide synthase | Apr 29, 2020 | Issued |
Array
(
[id] => 19105737
[patent_doc_number] => 11958818
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-16
[patent_title] => (R)-(2-methyloxiran-2-yl)methyl 4-bromobenzenesulfonate
[patent_app_type] => utility
[patent_app_number] => 17/607429
[patent_app_country] => US
[patent_app_date] => 2020-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3902
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17607429
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/607429 | (R)-(2-methyloxiran-2-yl)methyl 4-bromobenzenesulfonate | Apr 28, 2020 | Issued |
Array
(
[id] => 16238541
[patent_doc_number] => 20200255775
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-13
[patent_title] => SULFOPEROXYCARBOXYLIC ACIDS, THEIR PREPARATION AND METHODS OF USE AS BLEACHING AND ANTIMICROBIAL AGENTS
[patent_app_type] => utility
[patent_app_number] => 16/858873
[patent_app_country] => US
[patent_app_date] => 2020-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28154
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16858873
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/858873 | Sulfoperoxycarboxylic acids, their preparation and methods of use as bleaching and antimicrobial agents | Apr 26, 2020 | Issued |
Array
(
[id] => 17704488
[patent_doc_number] => 20220204494
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-30
[patent_title] => CRYSTAL FORM S4 OF THE PLK4 INHIBITOR (1R,2S)-(E)-2-(3-(4-((CIS-2,6-DIMETHYLMORPHOLINO)METHYL)STYRYL)- 1 H-IMIDAZOL-6- YL)-5'-METHOXYSPIRO[CYCLOPROPANE-1,3'-INDOLIN]-2'-ONE FUMARATE
[patent_app_type] => utility
[patent_app_number] => 17/605108
[patent_app_country] => US
[patent_app_date] => 2020-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8676
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17605108
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/605108 | Crystal form S4 of the PLK4 inhibitor (1R,2S)-(e)-2-(3-(4-((cis-2,6-dimethylmorpholino)methyl)styryl)-1 h-imidazol-6-yl)-5'-methoxyspiro[cyclopropane-1,3'-indolin]-2'-one fumarate | Apr 22, 2020 | Issued |
Array
(
[id] => 16390022
[patent_doc_number] => 20200330963
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-22
[patent_title] => NEAR INFRARED PHOTOCATALYST BASED ON TI02-COATED GOLD NANOPARTICLES
[patent_app_type] => utility
[patent_app_number] => 16/855128
[patent_app_country] => US
[patent_app_date] => 2020-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3166
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16855128
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/855128 | Near infrared photocatalyst based on TiO | Apr 21, 2020 | Issued |
Array
(
[id] => 20343077
[patent_doc_number] => 12466799
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-11-11
[patent_title] => Method for producing N,N-disubstituted benzthiazolyl-sulfenamides
[patent_app_type] => utility
[patent_app_number] => 17/605301
[patent_app_country] => US
[patent_app_date] => 2020-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 0
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17605301
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/605301 | Method for producing N,N-disubstituted benzthiazolyl-sulfenamides | Apr 21, 2020 | Issued |
Array
(
[id] => 16642038
[patent_doc_number] => 10919872
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-02-16
[patent_title] => Method for producing 2-alkylcarbonylnaphtho[2,3-b]furan-4,9-dione-related substance, and said related substance
[patent_app_type] => utility
[patent_app_number] => 16/851389
[patent_app_country] => US
[patent_app_date] => 2020-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22066
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 538
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16851389
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/851389 | Method for producing 2-alkylcarbonylnaphtho[2,3-b]furan-4,9-dione-related substance, and said related substance | Apr 16, 2020 | Issued |
Array
(
[id] => 16221189
[patent_doc_number] => 20200246305
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-06
[patent_title] => APPLICATION OF TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL TRPV3 IN DEVELOPING DRUG FOR PREVENTING OR TREATING PSORIASIS
[patent_app_type] => utility
[patent_app_number] => 16/849555
[patent_app_country] => US
[patent_app_date] => 2020-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9574
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16849555
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/849555 | Application of transient receptor potential cation channel TRPV3 in developing drug for preventing or treating psoriasis | Apr 14, 2020 | Issued |
Array
(
[id] => 17343566
[patent_doc_number] => 20220009897
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-13
[patent_title] => FLUIDIZED REACTION METHOD FOR SYNTHESIZING PROPYLENE OXIDE BY GAS PHASE EPOXIDATION OF PROPYLENE AND HYDROGEN PEROXIDE
[patent_app_type] => utility
[patent_app_number] => 17/296210
[patent_app_country] => US
[patent_app_date] => 2020-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24371
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 646
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17296210
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/296210 | Fluidized reaction method for synthesizing propylene oxide by gas phase epoxidation of propylene and hydrogen peroxide | Apr 13, 2020 | Issued |
Array
(
[id] => 17791944
[patent_doc_number] => 20220251035
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-11
[patent_title] => NAPHTHALENESULFONAMIDE COMPOUND, PREPARATION METHOD, AND APPLICATION
[patent_app_type] => utility
[patent_app_number] => 17/626505
[patent_app_country] => US
[patent_app_date] => 2020-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19692
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 202
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17626505
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/626505 | Naphthalenesulfonamide compound, preparation method, and application | Apr 12, 2020 | Issued |
Array
(
[id] => 16476147
[patent_doc_number] => 10851074
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-12-01
[patent_title] => Processes for the preparation of 2,5-furandicarboxylic acid and intermediates and derivatives thereof
[patent_app_type] => utility
[patent_app_number] => 16/841478
[patent_app_country] => US
[patent_app_date] => 2020-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 38274
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 163
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16841478
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/841478 | Processes for the preparation of 2,5-furandicarboxylic acid and intermediates and derivatives thereof | Apr 5, 2020 | Issued |
Array
(
[id] => 16190708
[patent_doc_number] => 20200231557
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-23
[patent_title] => PROCESSES FOR PREPARING 2,5-FURANDICARBOXYLIC ACID AND ESTERS THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/839367
[patent_app_country] => US
[patent_app_date] => 2020-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9437
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16839367
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/839367 | PROCESSES FOR PREPARING 2,5-FURANDICARBOXYLIC ACID AND ESTERS THEREOF | Apr 2, 2020 | Abandoned |